1. Home
  2. MGLD vs MCRB Comparison

MGLD vs MCRB Comparison

Compare MGLD & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Marygold Companies Inc.

MGLD

The Marygold Companies Inc.

SELL

Current Price

$1.02

Market Cap

50.8M

Sector

Finance

ML Signal

SELL

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$4.66

Market Cap

47.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGLD
MCRB
Founded
1996
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.8M
47.4M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
MGLD
MCRB
Price
$1.02
$4.66
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
6.4K
58.0K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,876,734.00
$789,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$4.32
52 Week High
$1.38
$29.98

Technical Indicators

Market Signals
Indicator
MGLD
MCRB
Relative Strength Index (RSI) 42.82 42.44
Support Level $0.90 $4.59
Resistance Level $1.07 $5.65
Average True Range (ATR) 0.07 0.33
MACD -0.00 0.06
Stochastic Oscillator 55.26 26.59

Price Performance

Historical Comparison
MGLD
MCRB

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: